Testing for HIV Is the Critical First Step of the Status Neutral Care Continuum.1
Determining whether someone is living with HIV or not can initiate their linkage to an HIV care provider if positive or will confirm their eligibility for further PrEP assessment if negative.2,3
Several resources are available for detailed education about HIV diagnostic testing:
The US Preventive Services Task Force (USPSTF) has given HIV screening a grade A recommendation for all pregnant persons and for all adolescents and adults aged 15 to 65 years.4 This grade indicates that their review found that there is high certainty that the net benefit of this service is substantial.
According to the USPSTF, adolescents younger than age 15 and adults older than age 65 should be screened if they are at increased risk of HIV acquisition.4 Furthermore, screening for HIV infection is recommended in all pregnant persons, including those who present in labor or at delivery whose HIV status is unknown. The full USPSTF recommendation has more information.
References:
- U.S. Department of Health and Human Services. HIV national strategic plan for the United States: a roadmap to end the epidemic 2021-2025. Updated on January 15, 2021. Accessed on October 29, 2021. https://www.hiv.gov/federal-response/hiv-national-strategic-plan/hiv-plan-2021-2025
- National HIV Curriculum. HIV diagnostic testing. Updated August 31, 2020. Accessed October 13, 2021. https://www.hiv.uw.edu/go/screening-diagnosis/diagnostic-testing/core-concept/all
- Centers for Disease Control and Prevention (CDC). Laboratory tests. Accessed October 13, 2021. https://www.cdc.gov/hiv/testing/laboratorytests.html
- U.S. Preventive Services Task Force. Human immunodeficiency virus (HIV) infection: screening. Published June 11, 2019. Accessed October 13, 2021. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening
Connect With Our Medical Experts
Find My ViiV MSL
Easily find the ViiV Medical Science Liaison (MSL) in your area.
Request a Scientific Discussion
Submit a request for additional information from a ViiV Medical Expert.
Contact Us
Chat Live
Get immediate assistance from a ViiV Healthcare Professional.
Call 1‑888‑226‑8434
Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)
Report an Adverse Event
To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at 1‑877‑844‑8872 or FDA at 1‑800‑332‑1088 or www.fda.gov/medwatch
Are you a US healthcare provider?
This web portal is intended as an educational resource for healthcare providers practicing in the United States. It may include information about products or uses that have not been approved by the US Food and Drug Administration.
If you are not a healthcare provider, please discuss any questions you have regarding your health or medicines with your doctor, pharmacist, or nurse.